BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38467087)

  • 1. ST6GAL1 is associated with poor response to chemoradiation in rectal cancer.
    Smithson M; Diffalha SA; Irwin RK; Williams G; McLeod MC; Somasundaram V; Bellis SL; Hardiman KM
    Neoplasia; 2024 May; 51():100984. PubMed ID: 38467087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sialyltransferase ST6GAL-1 mediates resistance to chemoradiation in rectal cancer.
    Smithson M; Irwin R; Williams G; Alexander KL; Smythies LE; Nearing M; McLeod MC; Al Diffalha S; Bellis SL; Hardiman KM
    J Biol Chem; 2022 Mar; 298(3):101594. PubMed ID: 35041825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologic response after neoadjuvant chemoradiotherapy in locally advanced rectal adenocarcinoma: experience from Sudan.
    Abdalla AA; Alawad AA; Ali HA
    Afr Health Sci; 2016 Sep; 16(3):750-754. PubMed ID: 27917208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Changes in Circulating Cell-Free DNA as an Early Predictor of Response to Chemoradiation in Rectal Cancer-A Pilot Study.
    Ong WL; Lunca S; Morarasu S; Musina AM; Puscasu A; Iacob S; Iftincai I; Marinca A; Ivanov I; Roata CE; Velenciuc N; Dimofte G
    Medicina (Kaunas); 2023 Sep; 59(10):. PubMed ID: 37893461
    [No Abstract]   [Full Text] [Related]  

  • 5. Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study.
    Hosseini S; Nguyen N; Mohammadianpanah M; Mirzaei S; Bananzadeh AM
    J Gastrointest Cancer; 2019 Dec; 50(4):716-722. PubMed ID: 29984382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ST6GAL1 inhibits metastasis of hepatocellular carcinoma via modulating sialylation of MCAM on cell surface.
    Zou X; Lu J; Deng Y; Liu Q; Yan X; Cui Y; Xiao X; Fang M; Yang F; Sawaki H; Sato T; Tan B; Lu X; Feng B; Kuno A; Narimatsu H; Gao C; Zhang Y
    Oncogene; 2023 Feb; 42(7):516-529. PubMed ID: 36528750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microarray profiling of mononuclear peripheral blood cells identifies novel candidate genes related to chemoradiation response in rectal cancer.
    Palma P; Cuadros M; Conde-Muíño R; Olmedo C; Cano C; Segura-Jiménez I; Blanco A; Bueno P; Ferrón JA; Medina P
    PLoS One; 2013; 8(9):e74034. PubMed ID: 24040155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival.
    Theodoropoulos G; Wise WE; Padmanabhan A; Kerner BA; Taylor CW; Aguilar PS; Khanduja KS
    Dis Colon Rectum; 2002 Jul; 45(7):895-903. PubMed ID: 12130878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression.
    Scott E; Archer Goode E; Garnham R; Hodgson K; Orozco-Moreno M; Turner H; Livermore K; Putri Nangkana K; Frame FM; Bermudez A; Jose Garcia Marques F; McClurg UL; Wilson L; Thomas H; Buskin A; Hepburn A; Duxfield A; Bastian K; Pye H; Arredondo HM; Hysenaj G; Heavey S; Stopka-Farooqui U; Haider A; Freeman A; Singh S; Johnston EW; Punwani S; Knight B; McCullagh P; McGrath J; Crundwell M; Harries L; Heer R; Maitland NJ; Whitaker H; Pitteri S; Troyer DA; Wang N; Elliott DJ; Drake RR; Munkley J
    J Pathol; 2023 Sep; 261(1):71-84. PubMed ID: 37550801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sialylation of EGFR by ST6GAL1 induces receptor activation and modulates trafficking dynamics.
    Ankenbauer KE; Rao TC; Mattheyses AL; Bellis SL
    J Biol Chem; 2023 Oct; 299(10):105217. PubMed ID: 37660914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interpretation of magnetic resonance imaging for locally advanced rectal carcinoma after preoperative chemoradiation therapy.
    Kuo LJ; Chern MC; Tsou MH; Liu MC; Jian JJ; Chen CM; Chung YL; Fang WT
    Dis Colon Rectum; 2005 Jan; 48(1):23-8. PubMed ID: 15690653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer.
    Wallin U; Rothenberger D; Lowry A; Luepker R; Mellgren A
    Dis Colon Rectum; 2013 Jul; 56(7):859-68. PubMed ID: 23739192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II clinical trial of preoperative combined chemoradiation for T3 and T4 resectable rectal cancer: preliminary results.
    Tjandra JJ; Reading DM; McLachlan SA; Gunn IF; Green MD; McLaughlin SJ; Millar JL; Pedersen JS
    Dis Colon Rectum; 2001 Aug; 44(8):1113-22. PubMed ID: 11535850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of beclin 1 expression with response to neoadjuvant chemoradiation therapy in patients with locally advanced rectal carcinoma.
    Zaanan A; Park JM; Tougeron D; Huang S; Wu TT; Foster NR; Sinicrope FA
    Int J Cancer; 2015 Sep; 137(6):1498-502. PubMed ID: 25708267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial.
    Garcia-Aguilar J; Chow OS; Smith DD; Marcet JE; Cataldo PA; Varma MG; Kumar AS; Oommen S; Coutsoftides T; Hunt SR; Stamos MJ; Ternent CA; Herzig DO; Fichera A; Polite BN; Dietz DW; Patil S; Avila K;
    Lancet Oncol; 2015 Aug; 16(8):957-66. PubMed ID: 26187751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNA expressions in rectal cancer as predictors of response to neoadjuvant chemoradiation therapy.
    Kheirelseid EA; Miller N; Chang KH; Curran C; Hennessey E; Sheehan M; Newell J; Lemetre C; Balls G; Kerin MJ
    Int J Colorectal Dis; 2013 Feb; 28(2):247-60. PubMed ID: 22903298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the ST6GAL1 sialyltransferase in regulating ovarian cancer cell metabolism.
    Jones RB; Silva AD; Ankenbauer KE; Britain CM; Chakraborty A; Brown JA; Ballinger SW; Bellis SL
    Glycobiology; 2023 Oct; 33(8):626-636. PubMed ID: 37364046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor deposits in rectal adenocarcinoma after neoadjuvant chemoradiation are associated with poor prognosis.
    Gopal P; Lu P; Ayers GD; Herline AJ; Washington MK
    Mod Pathol; 2014 Sep; 27(9):1281-7. PubMed ID: 24434897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The β-galactoside α2,6-sialyltranferase 1 (ST6GAL1) inhibits the colorectal cancer metastasis by stabilizing intercellular adhesion molecule-1 via sialylation.
    Zhou L; Zhang S; Zou X; Lu J; Yang X; Xu Z; Shan A; Jia W; Liu F; Yan X; Su H; Liang T; Zheng M; Zhang Y; Feng B
    Cancer Manag Res; 2019; 11():6185-6199. PubMed ID: 31308754
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.